APA (7th ed.) Citation

Strong, R., Miller, R. A., Antebi, A., Astle, C. M., Bogue, M., Denzel, M. S., . . . Richardson, A. (2016). Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. Aging Cell, 15(5), 872. https://doi.org/10.1111/acel.12496

Chicago Style (17th ed.) Citation

Strong, Randy, et al. "Longer Lifespan in Male Mice Treated with a Weakly Estrogenic Agonist, an Antioxidant, an α-glucosidase Inhibitor or a Nrf2-inducer." Aging Cell 15, no. 5 (2016): 872. https://doi.org/10.1111/acel.12496.

MLA (9th ed.) Citation

Strong, Randy, et al. "Longer Lifespan in Male Mice Treated with a Weakly Estrogenic Agonist, an Antioxidant, an α-glucosidase Inhibitor or a Nrf2-inducer." Aging Cell, vol. 15, no. 5, 2016, p. 872, https://doi.org/10.1111/acel.12496.